Patent · US Active

Anti-single-chain type IV collagen polypeptide antibody, pharmaceutical drug, diagnostic, preventive, or therapeutic drug for tumour containing the antibody

US9163080B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

NIPPON KAYAKU KABUSHIKI KAISHA · JP

Inventors

Makoto Morita · Tokyo, JP
Arihiro Tomura · Tokyo, JP
Kan Saiga · Tokyo, JP
Toshihiko Hayashi · Tokyo, JP
Hidemitsu Sugihara · Tokyo, JP
Kazuhiro Tokunaka · Tokyo, JP
Takamichi Sato · Saitama, JP
Yasutada Imamura · Tokyo, JP

Key dates

Filing date	May 7, 2013
Grant date	Oct 20, 2015
Priority date	—
Expiry date	Jun 23, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A monoclonal antibody, wherein the monoclonal antibody specifically binds to a single-chain type IV collagen polypeptide, and wherein the monoclonal antibody is obtained by a hybridoma line of Anti NK-Antigen monoclonal antibody #141 having Accession No: FERM BP-11300.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.